Welcome : Guest

Entero Medics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Entero Medics, Inc., which is principally involved in the Manufacture of Medical Device. Illustrated with 104 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-64295
Price: $3500
Company Type: Public
Pages: 108
Date: November 2016
Market Data Tables: 104

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Medical Devices......4
Table 1: Global Medical Device and Diagnostics Market (2014) in US$ Million......4
Table 2: Medical Device and Diagnostics Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anesthesia & Respiratory, Cardiology, Dental, Diabetic Care, Diagnostic Imaging, Drug Delivery, Ear, Nose, and Throat (ENT), Endoscopy, General & Plastic Surgery, In Vito Diagnostics, Nephrology, Neurology, Opthalmics, Orthopedics, Wound Management, and Others......5
Table 3: Medical Devices & Diagnostics (MD&D)'s Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Brazil, Canada, China, France, Germany, Italy, Japan, Russia, Spain, U.S., UK, and Others......6
Table 4: Global Medical Devices Market (2014) in US$ Million......7
Table 5: Medical Device Industry Market by Product Worldwide (2015) - Percentage Share Breakdown by Value Sales for Gloves, Syringes, Catheters, First Aid Kit, Bandage Dressings, Surgical Tools, Equipment, Wheelchair, Electric Scooter, Blood Pressure Monitors, Glucose Meters, Thermometers, Contact lenses, X-ray, ECG, Ultrasound, and MRI Physiological Monitors......8
Table 6: Medical Device Industry Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Consumables Supplies, Homecare & Consumer Products, Hospital-Based Diagnosis Products, and Hospital-Based Treatment Products......9
Table 7: Medical Device Sales by Region Worldwide (2015) - Percentage Share Breakdown by Value for Brazil, China, India, Russia, and Others......10
Table 8: Medical Devices Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Brazil, China, Germany, India, Japan, Russia, Spain, UK, USA, and Others......11
Table 9: Medical Devices Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Americas, Asia-Pacific, Europe, and Others......12
Table 10: Medical Devices Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cardiovascular, Dental, Diabetes SMBG & Int. Sol, Drug Delivery, Endoscopy, Energy-Based, Radiotherapy, Imaging, In-Vitro Diagnostics, Orthopedics, Surgical Instrument, Urology & Renal, Vision, Wound Care, and Others......13
Table 11: Medical Equipment and Supplies Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dental Surgery & Equipment, Disposable Equipment & Supplies, In Vitro Diagnostics, Ophthalmic Equipment, Otologic & Technical Aids, and Other......14
Table 12: Medical Devices Market by Country in Asia-Pacific (2015) - Percentage Share Breakdown by Value Sales for Australia, China, India, Japan, Korea, Malaysia, Taiwan, Thailand, and Vietnam......15
Table 13: Medical Device Market by Type in Australia (2015) - Percentage Share Breakdown by Value for Consumables, Dental Products, Diagnostic imaging, Orthopaedica and Prosthetics, Patient Aids, and Others......16
Table 14: Medical and Surgical Equipment Market by Category in Australia (2015) - Percentage Breakdown by Value for Dental Equipment and Supplies, Laboratory Apparatus and Furniture, Surgical and Medical Instruments, Surgical Appliances and Supplies, and Other Medical and Surgical Equipment......17
Table 15: Medical Devices Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Consumables, Dental, Diagnostic Imaging, Orthopaedic, Patient Aids, and Others......18
Table 16: Medical Devices Market in China (2014) in US$ Million......19
Table 17: Medical Devices Sales by Product in China (2015) - Percentage Market Share Breakdown by Value for Consumables, In Vitro Diagnostics, and Medical Equipment......20
Table 18: Medtech Market by Product in China (2015) - Percentage Share Breakdown by Value Sales for Capital Equipment, Implantables, In-Vitro Diagnostics, Personal Medical Equipment, Other High-Value Medical Devices, and Others......21
Table 19: Medical Equipment Market by Type in India (2015) - Percentage Share Breakdown by Value for Home care, Imaging (CT (Computed Tomography) Scan, Doppler, MRI (Magnetic Resonance Imaging), Ultrasound, X-Ray, Others), Patient Monitoring, and Therapeutic......22
Table 20: Medical Device Market by Type in New Zealand (2015) - Percentage Share Breakdown by Value for Consumables, Dental Products, Diagnostic imaging, Orthopaedica and Prosthetics, Patient Aids, and Others......23
Table 21: Medical Device Industry Market by Product in Taiwan (2015) - Percentage Share Breakdown by Value Sales for Gloves, Syringes, Catheters, First Aid Kit, Bandage Dressings, Surgical Tools, Equipment, Wheelchair, Electric Scooter, Blood Pressure Monitors, Glucose Meters, Thermometers, Contact lenses, and X-ray, ECG, Ultrasound, MRI, Physiological Monitors......24
Table 22: Medical Device Industry Market by Segment in Taiwan (2015) - Percentage Share Breakdown by Value Sales for Consumables Supplies, Homecare & Consumer Products, Hospital-Based Diagnosis Products, and Hospital-Based Treatment Products......25
Diabetes......26
Table 23: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......26
Table 24: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......27
Table 25: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......28
Table 26: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......29
Table 27: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......30
Table 28: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......31
Table 29: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......32
Table 30: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......33
Table 31: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......34
Table 32: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......35
Diabetes Drugs......36
Table 33: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......36
Table 34: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......37
Table 35: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......38
Table 36: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......39
Table 37: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......40
Table 38: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......41
Table 39: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......42
Table 40: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......43
Table 41: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......44
Table 42: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......45
Table 43: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......46
Non-Insulin Anti-Diabetic Drugs......47
Table 44: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......47
Diabetic Macular Edema (DME)......48
Table 45: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......48
Table 46: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......49
Insulin......50
Table 47: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......50
Table 48: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......51
Table 49: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......52
Table 50: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......53
Table 51: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......54
DPP-4 Inhibitors......55
Table 52: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......55
Table 53: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......56
Table 54: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......57
Table 55: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......58
Table 56: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......59
Table 57: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......60
DPP-4 type Diabetes Drugs......61
Table 58: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......61
Pulmonary Arterial Hypertension (PAH)......62
Table 59: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......62
Table 60: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......63
Table 61: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......64
Table 62: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......65
Table 63: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......66
Table 64: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......67
Table 65: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......68
Table 66: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......69
Table 67: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......70
Table 68: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......71
Gastrointestinal Drugs......72
Table 69: Gastrointestinal Market Worldwide (2015) in US$ Million......72
Table 70: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......73
Cardiovascular......74
Table 71: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......74
Medical Device Sterilization......75
Table 72: Market Shares of Leading Medical Device Sterilization Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Share Breakdown for Bioster A.S., Sterigenics International LLC, Steris-Isomedix, Inc., Synergy Health Plc, In-House Services, and Others......75
Table 73: Low-temperature Central Sterilization Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Canada, Europe, U.S, and Rest of the World......76
Table 74: Low-temperature Central Sterilization Market by Technology Worldwide (2015) - Percentage Share Breakdown by Volume for Ethylene Oxide (EO), Hydrogen Peroxide (HP), and Low-temperature Steam Formaldehyde (LTSF)......77
Table 75: Market Shares of Leading Medical Device Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Baxter International, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Covidien Public Limited Company, GE Healthcare, Johnson & Johnson, Koninklijke Philips N.V., Medtronic, Inc., Siemens Healthcare Corporation, and Others......78
Table 76: Market Shares of Leading Medical Device Manufacturers in the US (2014) - Percentage Breakdown by Value for Boston Scientific, Edwards Life sciences, Medtronic, St. Jude Medical and Others......79
Diabetes Drugs......80
Table 77: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......80
Table 78: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......81
Table 79: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......82
Insulin......83
Table 80: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......83
Table 81: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......84
Table 82: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......85
Table 83: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......86
Table 84: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......87
Table 85: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......88
Table 86: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......89
Table 87: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......90
Table 88: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......91
Table 89: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......92
Second-Generation Insulin......93
Table 90: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......93
Third-Generation Insulin......94
Table 91: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......94
Human Insulin......95
Table 92: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......95
DPP-4 Inhibitors......96
Table 93: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......96
Table 94: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......97
Table 95: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......98
Gastrointestinal Drugs......99
Table 96: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......99
Table 97: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......100
Table 98: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private-Label and Others......101
Table 99: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......102
Table 100: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......103
Digestive Tablets......104
Table 101: Market Shares of Leading Digestive Remedy Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Procter & Gamble Co., Reckitt Benckiser Plc, and Others......104
Table 102: Market Shares of Leading Digestive Tablet Brands in India (2014) - Percentage Breakdown by Value Sales for Hajmola, Satmola and Others......105
Table 103: Market Shares of Leading Stomach Remedy (Tablet) Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Procter & Gamble Co., and Others......106
Blood Pressure Monitors (Digital)......107
Table 104: Market Shares of Leading Digital Blood Pressure Monitor Manufacturers by Value Sales in Taiwan (2014) - Percentage Breakdown for Health & Life Co., Ltd., Microlife Corporation, Rossmax International Ltd., and Others......107